An enzyme-linked immunosorbent assay (ELISA) for detection of immunoglobulin M (IgM) antibodies against the periplasmatic flagellum of the Reiter treponeme is described. IgM in the test samples was bound to anti-IgM-coated microtest plates, and flagellum-specific IgM antibody was subsequently detected by incubation with a purified flagellum preparation and monospecific antiflagellum conjugate. Rheumatoid factor, antinuclear antibodies, or flagellumspecific IgG did not interfere. The specificity of the ELISA for IgM antibodies was 99.5% for sera from 200 blood donors and 98.6% for 147 patient sera that gave false-positive reactions in other syphilis serological tests. The sensitivity was 88.5% for sera from 87 patients with first-time primary syphilis, 93.5% for sera from 62 patients with first-time secondary syphilis, 21.4% for sera from 42 patients who were reinfected, and 0% for sera from 13 patients with late syphilis. Of the sera from 153 patients with treated syphilis, 7.2% had IgM antibodies, and sera from patients with primary or secondary syphilis generally had no IgM antibodies 6 months after treatment. The finding of IgM antibodies indicates that patients should receive antisyphilis treatment if they have not been treated recently, but a negative result does not exclude the possibility of active syphilis. The method may prove useful for the diagnosis of congenital syphilis in newborns.
Detection of immunoglobulin M (IgM) antibodies against treponemal antigens is important for the diagnosis of congenital syphilis (1, 7, 21) since IgM antibodies do not cross the intact placenta and the presence of IgM antibodies against treponemal antigens in newborns indicates active syphilis. The early appearance of IgM antibodies during infection suggests that the detection of IgM antibodies could also be useful as an early test for syphilis, especially in the serological surveillance of contacts of syphilis patients. IgM antibodies persist for shorter periods after treatment than do IgG antibodies. In theory, IgM antibodies are therefore useful for indicating whether active disease is present or has recently been present in a person with IgG antibodies.
Currently, the most common method for the detection of anti-treponemal IgM antibodies is the IgM fluorescent treponemal antibody absorption (FTA-ABS) test (1) . However, as in other indirect fluorescent-antibody tests for IgM antibodies, false-negative and -positive results may occur (4, 10, 16) . For increasing the specificity and sensitivity of the IgM FTA-ABS test, separation of IgG and IgM in sera by size chromatography or gradient centrifugation (10, 11) and subsequent testing of the fractions by IgM FTA-ABS test have been recommended.
Elsewhere, we described an enzyme-linked immunosorbent assay (ELISA) for IgG antibodies against the periplasmatic flagellum (axial filament) of the Reiter treponeme and showed that this method has a sensitivity and specificity comparable to those of the FTA-ABS test (15a) . Compared with the FTA-ABS test, the IgG ELISA has several advantages: it uses a purified, well-defined antigen from an in vitro cultivable treponeme, it does not involve preabsorption of sera, it is quantitative, it gives results that are read objectively, and it is less laborious.
In the present study, we developed, on basis of the principle originally described by Duermeyer and van (23) , and all other sera were tested by the cardiolipin Wassermann test as modified by Morch (CWRM) (20) and by the Kahn standard test (KR) (20) . The results of CWRM and KR (STS) were recorded as positive when a serum was reactive in one or both tests. All sera were analyzed by the FTA-ABS test (23) , and practically all were analyzed by the T. pallidium immobilization (TPI) test (14) as well. The conjugate used in the FTA-ABS test was a rabbit anti-human IgG, -A, -M antiserum (code F1009; DAKO-Immunoglobulins).
Diagnoses of syphilis. The diagnoses of syphilis were made on basis of extensive, centralized, serological and clinical data collected at the Department of Treponematoses, Statens Seruminstitut, Copenhagen.
Sera. Patient sera were chosen from specimens submitted for routine syphilis serological analysis during a 6-month period in 1980. From each patient except those in group 10 (see below), one serum sample was obtained. All sera were stored at -20°C until use. Most of the sera were from another study (15a) and were obtained from one of the following groups.
Group 1: patients with untreated primary syphilis. There were 87 patients with primary untreated syphilis. All patients had lesions suspected of being chancres, and all but four had sera that were reactive in STS or had treponemes found by dark-field microscopy. Of the four patients with nonreactive sera in STS and for whom dark-field microscopy was not done or was done with a negative result, all gave succeeding samples that were reactive in STS. All group 1 patients were considered to have syphilis for the first time.
Group 2: patients with untreated secondary syphilis. There were 62 patients with untreated secondary syphilis. All patients had exanthema, and all gave sera that were reactive in STS. We believed that these patients had syphilis for the first time.
Group 3: patients with untreated syphilitic reinfections. There were 42 patients with syphilitic reinfections. All patients had untreated primary syphilis (17 cases) or untreated secondary syphilis (25 cases). All patients had records of previously diagnosed and treated syphilis.
Group 4: patients with untreated late syphilis. There were 13 patients with untreated late syphilis. Four patients had late latent syphilis, and nine patients had tertiary syphilis. All sera were reactive in STS and the TPI and FTA-ABS tests. None of the patients had been previously treated for syphilis.
Group 5: patients with treated syphilis. There were 610 PEDERSEN, PETERSEN, AND AXELSEN found in no more than one treponemal test. None of the persons had any history or signs of syphilis. Fortyfive group 6 persons had sera that chronically gave false-positive reactions (i.e., sera that were serologically reactive for more than 6 months), 18 had sera that gave false-positive reactions acutely, and 84 were not followed long enough to ascertain whether their sera gave false-positive reactions acutely or chronically. mined by the anti-IgM ELISA is shown in Fig. 1 , and the results of all syphilis serological tests are shown in Table 2 . Seventy-seven (88.5%) of the sera from patients with untreated primary syphilis (group 1) were reactive in the anti-IgM ELISA, and six of those were nonreactive in the IgG ELISA. Ten (11.5%) of the sera were nonreactive in the antiIgM ELISA: of these, four were nonreactive in the IgG ELISA, and six were reactive.
Fifty-eight (93.5%) of the sera from patients with untreated secondary syphilis (group 2) were reactive in the anti-IgM ELISA. The sera of all patients were reactive in the other tests, and the differences in sensitivity between the anti-IgM ELISA and the other tests were not significant.
Only nine (21.4%) of the sera from patients who were reinfected (group 3) were reactive in the anti-IgM ELISA, whereas all were reactive in all of the other syphilis serological tests (P < 0.01).
The sera of all 13 patients with untreated late syphilis (group 4) were nonreactive in the antiIgM ELISA, but all were reactive in the other syphilis serological methods (P < 0.01). Eleven (7.2%) patients in the group with treated syphilis (group 5) had sera that were reactive in the anti-IgM ELISA. In comparison, 79.1% of the patients had sera that were reactive in the IgG ELISA (P < 0.01). Eight of the patients with IgM antibodies against the flagellum had been treated for syphilis <10 months previously. One patient was treated 15 months previously, one was treated 30 months previously, and one was treated 33 years previously. The 11 sera reactive in the anti-IgM ELISA were all reactive in the IgG ELISA and the FTA-ABS, and TPI tests. None of the sera had rheumatoid factor. Figure 2 shows the results of the consecutive samples (group 10). Most contained antinuclear antibodies (titer, .1:320).
Three rheumatoid factor-positive sera (RoseWaaler titer, -1:5,120) were diluted 1:100 and mixed in a 1:1 ratio with four sera diluted 1:100 that were reactive in the IgG ELISA and nonreactive in the anti-IgM ELISA. All 12 mixtures were nonreactive in the anti-IgM ELISA. None of the sera from newborns (group 9)
were reactive in the anti-IgM ELISA, but all were reactive in IgG ELISA and the FTA-ABS test.
DISCUSSION
After it was described in 1978 (5), the solidphase anti-IgM ELISA became the method of choice for the detection of IgM antibodies. The method eliminates competition between IgG and IgM antibodies for antigenic sites. This competition may cause false-negative IgM results both in the indirect ELISA (24) and in the indirect fluorescent-antibody tests (4, 10) such as the IgM FTA-ABS test. The anti-IgM ELISA to a certain degree also eliminates the interaction of rheumatoid factors, which may cause false-positive results in the indirect methods (16) . Rheumatoid factors may, however, also interact in the anti-IgM ELISA method (24) . The interaction is caused by the binding of IgM rheumatoid factor to anti-IgM antibodies bound to the microtest plate. Rheumatoid factor may be able to bind the conjugate even in absence of antigen. Naot et al. (13) obtained false-positive results only when both rheumatoid factor and antinuclear antibodies were present in the serum. Interactions of rheumatoid factors and antinuclear antibodies were not seen in the present study, not even when rheumatoid factor-containing sera were mixed with sera containing high levels of IgG antibodies against the flagellum. The addition of normal-rabbit serum to the conjugate decreased the nonspecific binding of the conjugate to the plate. A single serum that contained both rheumatoid factor and antinuclear antibodies would have given a false-positive reaction in the anti-IgM ELISA without the addition of rabbit serum.
Most of the sera from patients with untreated first-time primary syphilis (group 1) and secondary syphilis (group 2) were reactive in the antiIgM ELISA, but most of the sera from patients with untreated reinfections (group 3) and all of the sera from patients with untreated late syphilis (group 4) were nonreactive. For group 3, the high percentage of sera that were reactive in the IgG ELISA and the low percentage of sera that were reactive in the anti-IgM ELISA are characteristic of an anamnestic immune response in which T-cells are involved. The nonreactivity in the anti-IgM ELISA of sera from patients with late syphilis (group 4) can be explained similarly.
IgM FTA-ABS test results are conflicting and only to a certain degree in accordance with the present study. Muller (10) separated IgM and IgG in 1,582 sera from patients with latent, late latent, and neurosyphilis by size chromatography. Of these sera, 25.4% were reactive in the IgM FTA-ABS test before fractionation, and 54.0% were reactive after fractionation. Muller and Oelerich (12) showed that the IgM titers of fractionated sera from patients with late syphilis were lower than the titers of sera from patients with early syphilis and that most sera were reactive; for sera from reinfected patients, nonreactive IgM FTA-ABS test results were often seen. In a study by Atwood and Miller (2) (26) found that the number of positive IgM FTA-ABS test results for unfractionated sera from patients with late syphilis was considerably lower than that for unfractionated sera from patients with early syphilis. O'Neill and Nicol (15) found that all patients with late syphilis had sera that were reactive. The mechanism behind the production of IgM antibodies found in sera from reinfected patients and patients with late syphilis has not been elucidated, and the differences found in some of the studies are difficult to explain. The fixed treponemes used in the FTA-ABS test constitute a complex mosaic of antigens that may contain both T-celldependent and T-cell-independent antigens (e.g., polysaccharides). This may explain the IgM response in the IgM FTA-ABS test of sera from reinfected patients and patients with late syphilis. However, antibodies against purified treponeme polysaccharides in humans with syphilis have not been demonstrated (9) . The IgM antibodies in reinfected persons therefore may bind to previously unidentified T-cell-independent antigens or to epitopes not detected by the immune system the first time the patient had syphilis. Alternatively, the IgM antibodies may be produced by clones of B-lymphocytes hidden during the first infection.
Six sera from patients with primary syphilis were reactive in the anti-IgM ELISA and nonreactive in the IgG ELISA, indicating that the antiIgM ELISA has an acceptable sensitivity. However, the sera of 10 patients with primary and secondary syphilis (groups 1 and 2, respectively) were nonreactive in the anti-IgM ELISA, although they were reactive in the IgG ELISA and other syphilis serological tests. These 10 patients may have had syphilis previously if an IgM response is obligatory in the first infection. One of the patients had a sore on his penis 10 years previously that was suspected of being a chancre, but he was not treated at that time. Six of the 10 patients were foreigners and could have been treated for syphilis in their home countries without our knowledge. Of the other 139 patients in groups 1 and 2, only 13 were foreigners.
After treatment, the IgM antibodies decreased rapidly (group 10; Fig. 2) . However, the sera of three patients (group 5) were reactive more than 10 months after treatment. One of these patients had been treated 33 years earlier. We do not believe that this patient had late syphilis since the sera of all patients with late syphilis (Fig. 1 [group 4]) were nonreactive. Long-time duration of the IgM response in some patients has also been shown in the IgM FTA-ABS test (15, 26) .
The specificity of the anti-IgM ELISA was high: 98.6% for the patients whose sera gave false-positive reactions (group 6). In comparison, the specificity of the IgG ELISA was 93.2% (P < 0.05).
The anti-IgM ELISA might be useful for the serodiagnosis of neonatal congenital syphilis since interaction of rheumatoid factors and IgGIgM competition were not seen (16) . None of the sera from the newborns (group 9) with IgG antibodies from the mothers were reactive in the anti-IgM ELISA. Sera from children with congenital syphilis could not be investigated since this manifestation is extremely rare in Denmark, i.e., less than one case every 5 years.
In conclusion, the anti-IgM ELISA for antibodies against the flagellum may be a useful addendum to the IgG ELISA. An IgM-reactive serum indicates that the patient should receive antisyphilis treatment if he or she has not been treated recently. An IgM-nonreactive serum does not exclude the possibility that the patient needs treatment; in fact, the patient may be reinfected or have late untreated syphilis. The anti-IgM ELISA may assist in distinguishing between early latent syphilis (IgM reactive) and late latent syphilis (IgM nonreactive) and may prove useful for the diagnosis of congenital syphilis in newborns. Interference from rheumatoid factor and IgG-IgM competition are not experienced, and serum fractionation is not needed.
